October 27, 2009
By:Lisa Henderson
Co-founder of investment firm set to acquire MDS Global Central Labs speaks out about his purchase.
 |
October 22, 2009
By:Marissa Shapiro
Why knowing a drug's risk and preparing for a risk evaluation mitigation strategy early on will considerably benefit a drug's development.
|
October 1, 2009
By:Juliane Carvalho, Ekopimo Ibia
The region and its regulatory agencies try to keep up with the rapidly growing clinical trials market.
|
September 30, 2009
A recent, free report, reveals biotech professionals' evaluations of potential business model alternatives for the future.
|
September 11, 2009
By:David Levin
How changing times require a new approach to partnerships.
|
August 25, 2009
By:Peter O'Donnell
European Union focuses on adverse drug reaction research.
|
August 20, 2009
By:Michelle Perez
Taking advantage of the eCTD's cross-application feature, linking from NDA back to IND.
|
August 17, 2009
By:Kenneth A. Getz, John R. Vogel
Now with web exclusive charts and figures, a new survey captures sponsors changing global usage of, and relationships with, CRO partners.
|
July 31, 2009
By:Dan McDonald
Understanding common myths and truths surrounding one of the fastest growing clinical trial markets.
|
| 
